Trials / Sponsors / Medigen Biotechnology Corporation
Medigen Biotechnology Corporation
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Pati Pancreatic Carcinoma Stage II, Cholangiocarcinoma Resectable | Phase 1 / Phase 2 | 2024-10-21 |
| Recruiting | A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Rese Colon Cancer Stage I | Phase 1 | 2022-03-10 |
| Completed | A Phase I Study to Evaluate the Safety, Reactogenicity, and Humoral Immune Responses to an Inactivated H5N1 In Bird Flu, Avian Influenza, Influenza A(H5N1) | Phase 1 | 2012-08-01 |